Finance and markets: business, quotes, gold, energy and releases.
Found 44276 articles
Investors who purchased Peabody Energy Corporation securities between October 14, 2024, and May 4, 2026, face an August 24 deadline to join a potential securities fraud lawsuit. The litigation, spearheaded by Schall Brown & Schwartz LLP, centers on allegations that the company misled shareholders regarding the production schedule of its Centurion mine.
Investors who purchased First Solar shares between February 2025 and February 2026 face a critical deadline today to join a class action lawsuit. The litigation alleges the company misled the market regarding its manufacturing shift from Asia to the United States and its capacity to mitigate the impact of federal tariffs.
Investors holding Futu Holdings Limited stock between May 2023 and May 2026 have until August 25 to join a class action lawsuit. The litigation alleges the company misled shareholders by failing to disclose that its operations in China lacked essential licensing from the China Securities Regulatory Commission.
A class action lawsuit accuses Genius Group Limited of violating federal securities laws through a sophisticated spoofing operation. The legal action, filed in the wake of allegedly misleading market statements, invites shareholders who acquired GNS stock between April 12, 2022, and May 30, 2025, to seek potential recovery for their losses.
Investors who purchased Insulet Corporation shares between February 21, 2025, and May 26, 2026, face a looming August 31, 2026, deadline to join a class action lawsuit. The litigation alleges the medical device company violated federal securities laws by misleading the market regarding its manufacturing process controls.
A class action lawsuit alleges that Peabody Energy Corporation misled shareholders regarding the operational capacity of its Centurion mine. The complaint claims the company issued false growth guidance between October 14, 2024, and May 4, 2026, failing to disclose repeated production delays that impacted the firm's market value.
Investors holding Futu Holdings Limited securities have until August 25, 2026, to seek lead plaintiff status in a class action lawsuit filed against the company. The litigation alleges that Futu misled shareholders by failing to disclose persistent non-compliance with China Securities Regulatory Commission regulations between 2023 and 2026.
South Korean pharmaceutical firm GC Biopharma has secured regulatory approval for its Hunter syndrome treatment, Hunterase, in India and Taiwan. The move marks a strategic escalation of the company’s presence across Asian markets, where the drug aims to address significant unmet medical needs for patients living with the rare genetic disorder.
A potential $2.3 billion windfall awaits Hanmi Pharm after the Seoul-based drugmaker granted Genentech exclusive global rights to its experimental obesity treatment, HM17321. The deal, which excludes South Korea, positions the urocortin-2 analog as a challenger to existing incretin-based weight-loss therapies currently dominating the market.
A $2.3 billion licensing agreement signals a shift in obesity treatment as Seoul-based Hanmi Pharm partners with Genentech to advance HM17321, a novel urocortin-2 analog. The deal grants the Roche subsidiary global rights—excluding South Korea—to develop the candidate, which aims to preserve lean muscle mass during weight loss.
More than 400 students from ten countries gathered in Macao for the Future Liberal Arts Leadership Summit, a five-day intensive program focused on interdisciplinary approaches to global environmental challenges. The event, organized by the World Youth Forum and the International Academic Decathlon, concluded a 2026 series involving over 1,000 participants.
With 91% of tennis fans now relying on digital platforms during matches, IBM and the USTA are deploying a suite of AI-powered tools for the 2026 US Open. The collaboration introduces granular serve metrics and momentum analysis, aiming to transform raw court data into personalized, real-time insights for millions of viewers.
Managing a fragmented landscape of streaming services and platforms has become a source of mounting irritation for global sports fans. According to the latest IBM Sports Intelligence Report, nearly 40% of surveyed viewers express frustration with juggling multiple subscriptions, driving a clear preference for centralized, all-in-one digital experiences.
Eight million children remain out of school in Sudan as conflict enters its fourth year, leaving nearly half of the nation's youth without access to classrooms. To address this, Education Cannot Wait has launched a $22 million multi-year investment targeting nearly 200,000 students across West Darfur, South Kordofan, and Gedaref.
Addressing the 17th session of the UNCCD in Ulaanbaatar, LONGi founder Li Zhenguo argued that photovoltaic technology offers a critical buffer against climate-driven food instability. By integrating solar infrastructure with agricultural systems, the company aims to transform arid, unproductive landscapes into essential hubs for food and energy production.
Pulnovo Medical has enrolled its first two patients in the PULSE-LHD clinical trial at Henry Ford Hospital in Detroit, marking the formal U.S. launch of an investigation into Pulmonary Artery Denervation (PADN) as a potential treatment for pulmonary hypertension associated with left heart disease.
Advantech is pushing industrial automation into real-time vision reasoning with a new suite of edge AI hardware powered by the Qualcomm Dragonwing IQ-9075 processor. The rollout includes SMARC modules, robotic controllers, and fanless AI systems designed to handle 100 TOPS of performance while managing up to 16 concurrent camera feeds.
Miyu Yamashita dominated the Royal Mayfair Golf Club on Sunday, securing a wire-to-wire victory at the 2026 CPKC Women's Open. Her nine-stroke win coincided with a record-breaking charitable achievement for the tournament, which generated $4.95 million to advance heart healthcare initiatives across Alberta.
On August 18, Gravity Game Unite expanded its portfolio with the launch of Ragnarok Zero: Global across Southeast Asia, Europe, and Oceania. Operating under a subscription model, the new PC MMORPG blends the classic 2D aesthetic of the original franchise with modern quality-of-life updates and original user-generated content features.
South Korean biopharmaceutical firm Rznomics has secured a foothold in San Diego, joining Eli Lilly’s Gateway Labs innovation hub. This move grants the RNA-focused developer direct access to specialized wet lab facilities and a network of Lilly scientists, marking a strategic push to accelerate its global clinical infrastructure.
The Responsible Fintech Institute and technology partner Safeheron have launched a cross-jurisdictional pilot to test post-quantum cryptographic infrastructure for digital asset transfers. By integrating NIST-standard digital signatures with multi-party computation, the initiative aims to establish a secure, open-source framework for banks and regulators facing future quantum-driven cyber risks.
Antengene Corporation marked its first period of profitability in the first half of 2026, reporting 513 million RMB in revenue—an 864.5% surge compared to the previous year. The Shanghai-based biotech credits this financial milestone to a strategic pivot toward high-value global partnerships and the maturation of its internal R&D pipeline.
A securities fraud class action lawsuit has been filed against Cogent Communications Holdings, Inc. in the U.S. District Court for the District of Columbia. The litigation, initiated by the Southfield Fire and Police Retirement System, targets alleged misrepresentations regarding the company’s optical wavelength services and order backlog between February 2024 and May 2026.
Anbogen Therapeutics has signed a research agreement with the University of Tokyo’s Laboratory of Veterinary Surgery to test the drug candidate ABT-301 against naturally occurring solid tumors in canine models. The partnership seeks to bridge the gap between preclinical data and human clinical trials for resistant cancer types.
After seven weeks of intense competition, AG.AL emerged as the Esports World Cup 2026 Club Champion in Paris. The organization secured the $7 million top prize with 5,300 points, capping a dominant performance across 25 tournaments that drew a record-breaking global audience of 850 million viewers.
AG.AL has been crowned the 2026 Esports World Cup Club Champion, capping a seven-week global tournament in Paris. The organization secured the top spot and a $7 million prize after a dramatic final-weekend victory in Trackmania, outpacing two-time defending champions Team Falcons in the final overall standings.
Investors who held Photronics, Inc. securities between December 10, 2025, and May 27, 2026, face a critical September 4, 2026, deadline to seek lead plaintiff status in an ongoing class action lawsuit alleging the company misled shareholders regarding its product pipeline and growth projections.
Technical hiring is plagued by a recurring disconnect: engineers with deep expertise are routinely rejected, not due to a lack of ability, but because they fail to navigate the high-pressure performance art that the modern technical interview has become.
Thierry Ehrmann, founder and CEO of Artmarket.com, and his family are moving to increase their equity stake in the firm. This capital commitment underscores management’s confidence in the company’s ongoing transition toward proprietary, vertical AI solutions designed to enhance the global art market's data infrastructure.
Nineteen-year-old Max Alran delivered a career-defining performance on Saturday, charging down the technical Les Gets course to secure his first Elite Men’s Downhill World Cup win. Amid the rain-slicked terrain of the Haute-Savoie region, the French rider eclipsed the field with a blistering 3:27.924 finish time.